Long-term survival after regional chemotherapy for liver metastases from breast cancer. A case report

The prognosis of patients with liver metastases from breast cancer has to be regarded as rather unfavorable. A 45-year-old woman with cancer of the left breast and multiple simultaneous liver metastases was initially treated with cyclophosphamide, methotrexate, and 5-fluorouracil. After two treatment cycles a sonogram of the left breast revealed reduction of the tumor size and she underwent a modified radical mastectomy and hepatic artery catheterization. There was no change in the multiple lesions of the liver on abdominal ultrasonography. One week later a regional chemotherapy regimen was given through a hepatic arterial catheter with subcutaneous implanted reservoir. After completion of the seventh course of chemotherapy, ultrasonography revealed that the multiple liver metastases had regressed completely. To date (July 2001) there has been no relapse during the seven-year follow-up period. In conclusion, we suggest that intra-arterial regional chemotherapy may have an important role to play in the management of breast cancer patients with isolated liver metastases.     

Video-assisted extracorporeal appendectomy

BACKGROUND: Despite many randomized controlled trials, there are still several important doubts about laparoscopic appendectomy. Longer operative time and greater cost are the two major disadvantages of the laparoscopic technique. PATIENTS AND METHODS: In current techniques of laparoscopic appendectomy, the appendix is ligated and divided within the abdominal cavity. We have performed 423 laparoscopic appendectomies using an extracorporeal technique during the last 8 years. In this technique, the appendix is delivered to the surface through the cannula, and appendectomy is carried out extracorporally. RESULTS AND CONCLUSION: The extracorporeal technique of appendix removal can be performed as safely and efficiently as the open technique. We report our data on the series of 423 operations, in which we had the encouraging experience that the video-assisted extracorporeal technique is a practical and reasonable alternative to the traditional laparoscopic technique.     

Oromandibular-limb hypogenesis spectrum and maternal lithium use

A female is described with oromandibular-limb hypogenesis spectrum. The mother had taken lithium during the pregnancy.     

MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis?

Familial Mediterranean fever (FMF) is an autosomal recessive disease. It is characterized by recurrent febrile episodes in association with peritonitis, pleuritis, and arthritis. Progressive systemic amyloidosis is the most important complication of FMF that inevitably leads to chronic renal failure. Recently, the gene for FMF, MEFV, has been cloned and four missense mutations have been described: M694V, M680I, V726A, and M694I. Initial studies have suggested that the presence of the M694V mutation carries a significant risk for the development of amyloidosis. In this study, we present seven families, in which at least two individuals have been diagnosed with FMF and at least one with amyloidosis. Among 18 individuals, in whom molecular testing was performed for the four aforementioned mutations, ten had amyloidosis. None of these ten individuals was found to be homozygous for the M694V mutation. In three families, there were two sibs with amyloidosis. None of the sib-pairs with amyloidosis was found to have the same genotype. There were two or more sibs with the same genotype in four families. Only one sib from each family developed amyloidosis in these families. These results provide evidence that FMF patients without the M694V mutation are also at risk for the development of amyloidosis. Particular mutations themselves do not appear to be sufficient to explain the occurrence of amyloidosis in all cases with FMF.     

Malondialdehyde levels in serum of patients with skin cancer

The relationship of free radicals with some types of carcinomas is known, these studies have been performed on samples taken from the tumor tissue. In this study, the malondialdehyde levels in the serum of patients with skin cancer were studied and compared with a control group. The differences between malondialdehyde levels in these two groups were evaluated using Mann Whitney-U. There was a very statistically significant increase in malondialdehyde levels in serum of the skin cancer patients compared with the control group (p=0.0095, z=−2.59). Thus, increased serum malondialdehyde levels may be a sign of carcinoma. Received: 29 April 1997 / Accepted: 15 October 1997